Data from just a small number of people are less likely to be conclusive than those from larger groups
J., Lrrk2 pathogenic substitutions in Parkinsons disease
Oerlemans, E
L., La Morgia C., Carbonelli M., Savini G., De Negri A., Simonelli F., Sadun F., Caporali L., Maresca A., Liguori R., Baruzzi A., Zeviani M., Carelli V., Idebenone treatment in patients with OPA1-mutant dominant optic atrophy
Daily Protocol (7 days per week): Some practitioners prescribe daily injections for the initial 4-6 weeks, then transition to 5 days per week for maintenance
Courier, Clinton